by PEAK Medicals | 30 April 2024
HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
by PEAK Medicals | 6 February 2024
Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
by PEAK Medicals | 19 April 2023
HER2 in Breast, Lung & GI Cancers Welcome & general introduction into HER2 testing Sabina Berezowska HER2 as a biomarker in breast cancer Zsuzsanna Varga Treatment considerations for HER2-positive GI-cancers Florian Lordick Clinical implications of HER2 in lung...
by PEAK Medicals | 2 November 2022
BRCA Mutated Tumors Welcome & introduction by host Berna Özdemir BRCA as a biomarker: the who, when and how in BRCA testing Elena Guerini-Rocco Treatment considerations for BRCA mut. ovarian cancer Isabelle Ray-Coquard BRCA in prostate cancer: prognostic and...
